These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17669615)

  • 1. [What's new in hemodialysis].
    Canaud B
    Presse Med; 2007 Dec; 36(12 Pt 2):1843-8. PubMed ID: 17669615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium and phosphate control by dialysis treatments.
    Messa P; Cerutti R; Brezzi B; Alfieri C; Cozzolino M
    Blood Purif; 2009; 27(4):360-8. PubMed ID: 19295199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrapure dialysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation.
    Lederer SR; Schiffl H
    Nephron; 2002 Jul; 91(3):452-5. PubMed ID: 12119476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nutritional status, comorbidity, and inflammation in hemodialysis].
    Fernández-Reyes MJ; Alvarez-Ude F; Sánchez R; Mon C; Iglesias P; Vázquez A
    Nefrologia; 2000; 20(6):540-9. PubMed ID: 11217649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular calcifications as a footprint of increased calcium load and chronic inflammation in uremic patients: a need for a neutral calcium balance during hemodialysis?
    Tetta C; Gallieni M; Panichi V; Brancaccio D
    Int J Artif Organs; 2002 Jan; 25(1):18-26. PubMed ID: 11853066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients.
    Kwan BC; Chow KM; Ma TK; Cheng PM; Leung CB; Li PK; Szeto CC
    Nephron Clin Pract; 2013; 123(3-4):246-53. PubMed ID: 24008429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why does three times per week hemodialysis provide inadequate dialysis for children?
    Fischbach M; Zaloszyc A; Laetitia H; Menouer S; Terzic J
    Hemodial Int; 2014 Oct; 18 Suppl 1():S39-42. PubMed ID: 25330830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis.
    Toussaint N; Boddington J; Simmonds R; Waldron C; Somerville C; Agar J
    Hemodial Int; 2006 Jul; 10(3):280-6. PubMed ID: 16805890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to hemodialysis.
    Pierratos A
    Annu Rev Med; 2004; 55():179-89. PubMed ID: 14746516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis.
    Arizono K; Nomura K; Motoyama T; Matsushita Y; Matsuoka K; Miyazu R; Takeshita H; Fukui H
    Blood Purif; 2004; 22 Suppl 2():26-9. PubMed ID: 15655319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum C-reactive protein level and its related factors in hemodialysis patients in Sari, Iran.
    Baradari AG; Emami Zeydi A; Espahbodi F; Shahmohammadi S
    Pak J Biol Sci; 2011 May; 14(10):595-9. PubMed ID: 22097096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers.
    Sabry AA; Elshafey EM; Alsaran K; Shalaby M; Alsherbeiny S; Abdelkader M
    Hemodial Int; 2014 Jul; 18(3):674-9. PubMed ID: 24467342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.